newsfilter
← Latest News
GlobeNewswire·

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

  • Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) announced that President & CEO Rich Daly & its management team will attend the Bank of America CNS Therapeutics Virtual Conference.
  • The presentation is scheduled for Monday, December 8, 2025, at 12:35pm ET.
  • The webcast will stream live via the Investors section of Catalyst's website at www.catalystpharma.com, with a replay available for at least 30 days.
  • Catalyst is a Coral Gables, Fla.-based biopharmaceutical company focused on in-licensing, developing, & commercializing treatments for rare diseases.
  • The company was named to the Forbes 2025 list of America's Most Successful Mid-Cap Companies & the 2025 Deloitte Technology Fast 500™ list.
  • Forward-looking statements in the release are subject to risks outlined in Catalyst's Form 10-K for fiscal year 2024 & subsequent SEC filings.
  • Investor inquiries can be directed to Melissa Kendis at (305) 420-3200 or IR@catalystpharma.com.
  • Media inquiries should be directed to Russo Partners representatives David Schull or Olipriya Das.